Erik Danielsen - Net Worth and Insider Trading

Erik Danielsen Net Worth

The estimated net worth of Erik Danielsen is at least $1,045 dollars as of 2024-11-13. Erik Danielsen is the CFO of Nymox Pharmaceutical Corp and owns about 20,900 shares of Nymox Pharmaceutical Corp (NYMXF) stock worth over $1,045. Details can be seen in Erik Danielsen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erik Danielsen has not made any transactions after 2018-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Erik Danielsen

To

Erik Danielsen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erik Danielsen owns 1 companies in total, including Nymox Pharmaceutical Corp (NYMXF) .

Click here to see the complete history of Erik Danielsen’s form 4 insider trades.

Insider Ownership Summary of Erik Danielsen

Ticker Comapny Transaction Date Type of Owner
NYMXF Nymox Pharmaceutical Corp 2018-12-21 Chief Financial Officer

Erik Danielsen Latest Holdings Summary

Erik Danielsen currently owns a total of 1 stock. Erik Danielsen owns 20,900 shares of Nymox Pharmaceutical Corp (NYMXF) as of December 21, 2018, with a value of $1,045.

Latest Holdings of Erik Danielsen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NYMXF Nymox Pharmaceutical Corp 2018-12-21 20,900 0.05 1,045

Holding Weightings of Erik Danielsen


Erik Danielsen Form 4 Trading Tracker

According to the SEC Form 4 filings, Erik Danielsen has made a total of 0 transactions in Nymox Pharmaceutical Corp (NYMXF) over the past 5 years. The most-recent trade in Nymox Pharmaceutical Corp is the acquisition of 6,000 shares on December 21, 2018, which cost Erik Danielsen around $8,100.

Insider Trading History of Erik Danielsen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Erik Danielsen Trading Performance

GuruFocus tracks the stock performance after each of Erik Danielsen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erik Danielsen is 61.64%. GuruFocus also compares Erik Danielsen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erik Danielsen within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Erik Danielsen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Erik Danielsen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 60.8 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 52.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Erik Danielsen Ownership Network

Ownership Network List of Erik Danielsen

No Data

Ownership Network Relation of Erik Danielsen

Insider Network Chart

Erik Danielsen Owned Company Details

What does Nymox Pharmaceutical Corp do?

Who are the key executives at Nymox Pharmaceutical Corp?

Erik Danielsen is the Chief Financial Officer of Nymox Pharmaceutical Corp. Other key executives at Nymox Pharmaceutical Corp include director & 10 percent owner & CEO Paul Averback , and director & General Counsel Randall J Lanham .

Nymox Pharmaceutical Corp (NYMXF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nymox Pharmaceutical Corp (NYMXF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nymox Pharmaceutical Corp (NYMXF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nymox Pharmaceutical Corp (NYMXF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nymox Pharmaceutical Corp Insider Transactions

No Available Data

Erik Danielsen Mailing Address

Above is the net worth, insider trading, and ownership report for Erik Danielsen. You might contact Erik Danielsen via mailing address: 9900 Cavendish Blvd, St Laurent A8 H4m 2v2.